In this study, we explored whether targeting radiation-induced senescence-like fibroblasts with FOXO4-DRI could have a “1 stone, 2 birds” effect — i.e., to decrease NSCLC cells’ radioresistance and reduce RIPF. Here, FOXO4 is linked to non-small cell lung carcinoma.